Form EFFECT Kezar Life Sciences,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 |
| Accession Number: | 0001140361-26-020547 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JinkoSolar Unveils Tiger Neo 5.0 All-Black Residential Solar Module with 25.52% Efficiency
- OMODA & JAECOO Launches Full Lifecycle Carbon Management Service, Releases Sino-European Mutually Recognised LCA Report for JAECOO 7 SHS
- XRP Price Today: XRP Near $1.30 Gets Ripple’s Institutional RWA Perpetuals Push as Remittix Combines PayFi and Markets
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share